Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time

Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time

Purpose: To assess the real-world effectiveness of enzyme replacement therapy (ERT; elosulfase alfa) on endurance in the treatment of mucopolysaccharidosis type IVA (MPS IVA) using cross-sectional data. Methods: The 6-minute walk test (6MWT) distances of ERT-treated and untreated participants from t...

Full description

Saved in:
Bibliographic Details
Main Authors: Barbara K. Burton, Karolina M. Stepien, Philippe M. Campeau, Jaim Sutton, Abigail Hunt, Pascal Reisewitz, David Hinds
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Genetics in Medicine Open
Subjects:
6-minute walk test
Cross-sectional
Mucopolysaccharidosis IVA
Multivariate analysis
Registry
Online Access:http://www.sciencedirect.com/science/article/pii/S2949774425014670
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items